In fact, from Merck's $1.3 billion deal to GSK's $850 million investment, the "gold content" of Chinese companies' self-developed TCE bispecific antibodies has already been well proven. The new moves ...
When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...
Pennsylvania Rep. Chris Deluzio joined Massachusetts Sen. Edward Markey to introduce the All Aboard Act, a bill that would ...
Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.
Inquirer on MSN3h
We’re eating too much plastic—what to do?A recent study, published in the journal Chemosphere and taken up widely by news outlets, shows that many black plastic household products contain brominated flame retardants, which are possibly ...
Invikafusp alfa has gained FDA fast track designation for treating TMB-H metastatic colorectal cancer. Invikafusp alfa ...
Phase 1 data indicate invikafusp alfa's potential as a precision cancer immunotherapeutic in solid tumors that have ...
A Danish study has found that semaglutide, which controls blood glucose while ensuring weight loss, is associated with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback